>Mercado de dispositivos médicos implantables activos en Oriente Medio y África, por producto (dispositivos de terapia de resincronización cardíaca (TRC-D), desfibriladores cardioversores implantables, marcapasos cardíacos implantables, implantes oculares, neuroestimuladores, dispositivos auditivos implantables activos, dispositivos de asistencia ventricular, monitores cardíacos implantables/registradores de bucle insertables, braquiterapia, monitores de glucosa implantables, implantes de pie caído, implantes de hombro, bombas de infusión implantables y accesorios implantables), tipo de cirugía (métodos quirúrgicos tradicionales y cirugía mínimamente invasiva), procedimiento (neurovascular, cardiovascular, auditivo y otros), usuario final (hospitales, clínicas especializadas, centros quirúrgicos ambulatorios, clínicas), país (Sudáfrica y resto de Oriente Medio y África), tendencias de la industria y pronóstico hasta 2028
Análisis y perspectivas del mercado: mercado de dispositivos médicos implantables activos en Oriente Medio y África
Se espera que el mercado de dispositivos médicos implantables activos de Oriente Medio y África gane un crecimiento significativo en el período de pronóstico de 2021 a 2028. Data Bridge Market Research analiza que el mercado está creciendo con una CAGR del 4,6% en el período de pronóstico de 2021 a 2028 y se espera que alcance los USD 945,75 millones para 2028. El aumento de los ingresos disponibles y el aumento en el desarrollo de nuevos productos son los principales impulsores del crecimiento del mercado en el período de pronóstico. La presencia de importantes actores del mercado está brindando una gran oportunidad para que el mercado crezca. Sin embargo, el alto costo de los dispositivos implantables está desafiando el crecimiento del mercado.
Los dispositivos médicos implantables activos son dispositivos eléctricos que se insertan en el cuerpo de un paciente mediante un procedimiento quirúrgico y están destinados a permanecer en el cuerpo del paciente después del procedimiento.
Se espera que el mercado de estos dispositivos aumente debido a las actividades de I+D y al lanzamiento de nuevos productos por parte de los fabricantes. Sin embargo, se espera que las limitaciones asociadas a los efectos secundarios nocivos y los costos limiten el crecimiento del mercado en el período de pronóstico.
El informe de mercado de dispositivos médicos implantables activos de Oriente Medio y África proporciona detalles de la participación de mercado, nuevos desarrollos y análisis de la cartera de productos, el impacto de los actores del mercado nacional y localizado, analiza las oportunidades en términos de bolsas de ingresos emergentes, cambios en las regulaciones del mercado, aprobaciones de productos, decisiones estratégicas, lanzamientos de productos, expansiones geográficas e innovaciones tecnológicas en el mercado. Para comprender el análisis y el escenario del mercado, comuníquese con nosotros para obtener un informe de analista; nuestro equipo lo ayudará a crear una solución de impacto en los ingresos para lograr su objetivo deseado.
Alcance y tamaño del mercado de dispositivos médicos implantables activos en Oriente Medio y África
El mercado de dispositivos médicos implantables activos de Medio Oriente y África está segmentado según el producto, el tipo de cirugía, el procedimiento y los usuarios finales.
- On the basis of product, the Middle East and Africa active medical implantable devices market is segmented into Cardiac Resynchronization Therapy Devices (CRT-D), implantable cardioverter defibrillators, implantable cardiac pacemakers, eye implants, neurostimulators, active implantable hearing devices, ventricular assist devices, implantable heart monitors/ insertable loop recorders, brachytheraphy, implantable glucose monitors, dropped foot implants, shoulder implants, implantable infusion pumps and implantable accessories. In 2021, Cardiac Resynchronization Therapy Devices (CRT-D) segment is expected to dominate the market as its efficiency and results are accurate.
- On the basis of surgery type, the Middle East and Africa active medical implantable devices market is segmented into traditional surgical methods and minimally invasive surgery. In 2021, traditional surgical methods segment is expected to dominate the market as it have less complication and expense of the treatment.
- On the basis of procedure, the Middle East and Africa active medical implantable devices market is segmented into neurovascular, cardiovascular, hearing and others. In 2021, cardiovascular is expected to dominate the market with the increase in cardiovascular disease.
- On the basis of end-users, the Middle East and Africa active medical implantable devices market is segmented into hospitals, specialty clinics, ambulatory surgical centers and clinics. In 2021, hospital segment is expected to dominate the market due growing demand of active medical implantable devices there.
Middle East & Africa Active Medical Implantable Devices Market Country Level Analysis
The active medical implantable devices market is analyzed and market size information is provided on the basis of product, surgery type, procedure, and end users.
The countries covered in the Middle East & Africa active medical implantable devices market report are the South Africa and Rest of Middle East and Africa.
Active medical implantable devices segment in Middle East & Africa region is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 because of increasing number of active medical implantable devices manufacturers and R&D activities. South Africa is leading the growth of the Middle East & Africa active medical implantable devices market and cardiovascular segment is dominating in this country due to increase in incidence of disease in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Middle East & Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Rising new product developments are boosting the market growth of active medical implantable devices
Middle East & Africa Active medical implantable devices market also provides you with detailed market analysis for every country growth in active medical implantable devices industry with Active medical implantable devices drugs sales, impact of advancement in the active medical implantable devices technology and changes in regulatory scenarios with their support for the market. The data is available for historic period 2010 to 2018.
Competitive Landscape and Active medical implantable devices Market Share Analysis
Active medical implantable devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, and technology lifeline curve. The above data points provided are only related to the company’s focus related to Active medical implantable devices market.
The major companies which are dealing in the Middle East and Africa active medical implantable devices market are NeuroPace, Inc., Axonics, Inc., Stimwave LLC, NEVRO CORP, Second Sight, BIOTRONIK, ABIOMED, Boston Scientific Corporation, Medtronic, Abbott, Eckert & Ziegler., Sonova, MED-EL Medical Electronics among others.
Several product launches and agreements are also initiated by the companies worldwide, which are also accelerating the growth of the active medical implantable devices market.
For instance,
- In August 2020, Medtronic announced the acquisition of Companion Medical, a private company manufacturer of InPen. This will expand the company’s ability to better serve people with diabetes.
- In July 2021, Abbott announced the launch of insert able cardiac monitor, Jot Dx in U.S. The device helps clinicians to view abnormal heart rhythm and allows for remote detection and improved diagnosis accuracy of cardiac arrhythmia. This will help the company to further acquire the market in coming years.
SKU-
Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo
- Panel de análisis de datos interactivo
- Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
- Acceso de analista de investigación para personalización y consultas
- Análisis de la competencia con panel interactivo
- Últimas noticias, actualizaciones y análisis de tendencias
- Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Tabla de contenido
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 MARKET APPLICATION COVERAGE GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 INDUSTRY INSIGHTS
5 REGULATORY ANALYSIS
5.1 REGULATION IN EUROPE
5.2 REGULATION IN U.S.
5.3 REGULATION IN CANADA
5.4 REGULATION IN CHINA
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 TECHNOLOGICAL ADVANCEMENT
6.1.2 INCREASING BURDEN OF CARDIOVASCULAR DISEASES, NEUROLOGICAL DISORDERS AND HEARING DISORDERS
6.1.3 INCREASING FDA APPROVAL
6.1.4 RISING AWARENESS FOR MEDICAL IMPLANTS
6.2 RESTRAINTS
6.2.1 HIGH COST OF MEDICAL IMPLANTS
6.2.2 INCREASING RISK OF DEVELOPING INFECTION AND OTHER COMPLICATIONS
6.3 OPPORTUNITIES
6.3.1 INCREASE IN DEMAND FOR MINIMALLY INVASIVE SURGERIES
6.3.2 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS
6.3.3 INCREASE IN THE GERIATRIC POPULATION
6.3.4 RISING HEALTHCARE INFRASTRUCTURE
6.4 CHALLENGES
6.4.1 INCREASING PRODUCT RECALL
6.4.2 SUPPLY CHAIN DISRUPTION DUT TO COVID-19 PANDEMIC OUTBREAK
7 IMPACT OF COVID-19
7.1 IMPACT ON PRICE
7.2 IMPACT ON DEMAND
7.3 IMPACT ON SUPPLY
7.4 STRATEGIC DECISIONS OF GOVERNMENT AND MANUFACTURERS
7.5 CONCLUSION
8 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 CARDIAC RESYNCHRONIZATION THERAPY DEVICES (CRT-D)
8.3 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
8.3.1 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
8.3.1.1 DUAL-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
8.3.1.2 BIVENTRICULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICDS)/ CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS (CRT-DS)
8.3.1.3 SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
8.3.2 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
8.4 IMPLANTABLE CARDIAC PACEMAKERS
8.4.1 DUAL CHAMBER PACEMAKERS
8.4.2 BIVENTRICULAR PACEMAKERS
8.4.3 SINGLE CHAMBER PACEMAKERS
8.5 EYE IMPLANTS
8.6 NEUROSTIMULATORS
8.6.1 SPINAL CORD STIMULATORS
8.6.2 DEEP BRAIN STIMULATORS
8.6.3 BLADDER STIMULATORS
8.6.4 GASTRIC NERVE STIMULATORS
8.6.5 SACRAL NERVE STIMULATORS
8.6.6 LIMB FUNCTION STIMULATORS
8.6.7 VAGUS STIMULATORS
8.6.8 OTHERS
8.7 ACTIVE IMPLANTABLE HEARING DEVICES
8.8 VENTRICULAR ASSIST DEVICES
8.9 IMPLANTABLE HEART MONITORS/ INSERTABLE LOOP RECORDERS
8.1 BRACHYTHERAPY
8.11 IMPLANTABLE GLUCOSE MONITORS
8.12 DROPPED FOOT IMPLANTS
8.13 SHOULDER IMPLANTS
8.14 IMPLANTABLE INFUSION PUMPS
8.15 IMPLANTABLE ACCESSORIES
8.15.1 LEAD
8.15.2 ELECTRODES
8.15.3 ADAPTORS
8.15.4 OTHERS
9 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE
9.1 OVERVIEW
9.2 TRADITIONAL SURGICAL METHODS
9.3 MINIMALLY INVASIVE SURGERY
10 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE
10.1 OVERVIEW
10.2 CARDIOVASCULAR
10.3 NEUROLOGICAL
10.4 HEARING
10.5 OTHERS
11 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITALS
11.3 AMBULATORY SURGICAL CENTERS
11.4 SPECIALIZED CLINICS
11.5 CLINICS
12 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION
12.1 MIDDLE EAST AND AFRICA
12.1.1 SOUTH AFRICA
12.1.2 REST OF MIDDLE EAST AND AFRICA
13 MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
14 COMPANY PROFILE
14.1 MEDTRONIC
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.2 ABBOTT
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENTS
14.3 BOSTON SCIENTIFIC CORPORATION
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 COCHLEAR LTD
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENT
14.5 ABIOMED
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 COMPANY SHARE ANALYSIS
14.5.4 PRODUCT PORTFOLIO
14.5.5 RECENT DEVELOPMENTS
14.6 AXONICS, INC.
14.6.1 COMPANY SNAPSHOT
14.6.2 REVENUE ANALYSIS
14.6.3 PRODUCT PORTFOLIO
14.6.4 RECENT DEVELOPMENTS
14.7 BIOTRONIK SE & CO. KG
14.7.1 COMPANY SNAPSHOT
14.7.2 PRODUCT PORTFOLIO
14.7.3 RECENT DEVELOPMENTS
14.8 DEMANT A/S
14.8.1 COMPANY SNAPSHOT
14.8.2 REVENUE ANALYSIS
14.8.3 PRODUCT PORTFOLIO
14.8.4 RECENT DEVELOPMENT
14.9 ECKERT & ZIEGLER.
14.9.1 COMPANY SNAPSHOT
14.9.2 REVENUE ANALYSIS
14.9.3 PRODUCT PORTFOLIO
14.9.4 RECENT DEVELOPMENTS
14.1 GLUSENSE
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENTS
14.11 MED-EL MEDICAL ELECTRONICS
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENTS
14.12 MICROSON
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT DEVELOPMENTS
14.13 NANO RETINA
14.13.1 COMPANY SNAPSHOT
14.13.2 PRODUCT PORTFOLIO
14.13.3 RECENT DEVELOPMENT
14.14 NEUROPACE, INC.
14.14.1 COMPANY SNAPSHOT
14.14.2 REVENUE ANALYSIS
14.14.3 PRODUCT PORTFOLIO
14.14.4 RECENT DEVELOPMENT
14.15 NEVRO CORP.
14.15.1 COMPANY SNAPSHOT
14.15.2 REVENUE ANALYSIS
14.15.3 PRODUCT PORTFOLIO
14.15.4 RECENT DEVELOPMENTS
14.15.5 RECENT DEVELOPMENTS
14.16 OTICON MEDICAL
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENTS
14.17 SECOND SIGHT
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.17.3 RECENT DEVELOPMENT
14.18 SONOVA
14.18.1 COMPANY SNAPSHOT
14.18.2 REVENUE ANALYSIS
14.18.3 PRODUCT PORTFOLIO
14.18.4 RECENT DEVELOPMENTS
14.19 STIMWAVE LLC
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENT
14.2 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD
14.20.1 COMPANY SNAPSHOT
14.20.2 PRODUCT PORTFOLIO
14.20.3 RECENT DEVELOPMENT
15 QUESTIONNAIRE
16 RELATED REPORTS
Lista de Tablas
TABLE 1 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 2 MIDDLE EAST & AFRICA CARDIAC RESYNCHRONIZATION THERAPY DEVICES (CRT-D) IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 3 MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 4 MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 5 MIDDLE EAST & AFRICA TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 6 MIDDLE EAST & AFRICA IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA EYE IMPLANTS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA NEUROSTIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA NEUROSTIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE HEARING DEVICES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA VENTRICULAR ASSIST DEVICES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA IMPLANTABLE HEART MONITORS/ INSERTABLE LOOP RECORDERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA BRACHYTHERAPY IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA IMPLANTABLE GLUCOSE MONITORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA DROPPED FOOT IMPLANTS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA SHOULDER IMPLANTS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA IMPLANTABLE INFUSION PUMPS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA TRADITIONAL SURGICAL METHODS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGERY IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 25 MIDDLE EAST & AFRICA CARDIOVASCULAR IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 MIDDLE EAST & AFRICA NEUROLOGICAL IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 MIDDLE EAST & AFRICA HEARING IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 MIDDLE EAST & AFRICA OTHERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA HOSPITALS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA AMBULATORY SURGICAL CENTERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA SPECIALIZED CLINICS IN BREAST RECONSTRUCTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA CLINICS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 MIDDLE EAST AND AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 35 MIDDLE EAST AND AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 36 MIDDLE EAST AND AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 37 MIDDLE EAST AND AFRICA TRANS VENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 38 MIDDLE EAST AND AFRICA IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 39 MIDDLE EAST AND AFRICA NEURO STIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 40 MIDDLE EAST AND AFRICA IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 41 MIDDLE EAST AND AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)
TABLE 42 MIDDLE EAST AND AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 43 MIDDLE EAST AND AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 44 SOUTH AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 45 SOUTH AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 46 SOUTH AFRICA TRANS VENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 47 SOUTH AFRICA IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 48 SOUTH AFRICA NEURO STIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 49 SOUTH AFRICA IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 50 SOUTH AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)
TABLE 51 SOUTH AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 52 SOUTH AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 53 REST OF MIDDLE EAST AND AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
Lista de figuras
FIGURE 1 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 SURGERY TYPE LIFELINE CURVE
FIGURE 7 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: SEGMENTATION
FIGURE 12 THE INCREASE IN DEMAND FOR ACTIVE MEDICAL IMPLANTABLE DEVICES EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 CARDIOVASCULAR SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET IN 2021 & 2028
FIGURE 14 NORTH AMERICA IS EXPECTED TO DOMINATE THE MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET
FIGURE 16 AGING POPULATION IN THE WORLD (IN MILLION)
FIGURE 17 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PRODUCT, 2020
FIGURE 18 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PRODUCT, 2019-2028 (USD MILLION)
FIGURE 19 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PRODUCT, CAGR (2021-2028)
FIGURE 20 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 21 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY SURGERY TYPE, 2020
FIGURE 22 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY SURGERY TYPE, 2019-2028 (USD MILLION)
FIGURE 23 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY SURGERY TYPE, CAGR (2021-2028)
FIGURE 24 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY SURGERY TYPE, LIFELINE CURVE
FIGURE 25 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PROCEDURE, 2020
FIGURE 26 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PROCEDURE, 2019-2028 (USD MILLION)
FIGURE 27 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PROCEDURE, CAGR (2021-2028)
FIGURE 28 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PROCEDURE, LIFELINE CURVE
FIGURE 29 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY END USER, 2020
FIGURE 30 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY END USER, 2019-2028 (USD MILLION)
FIGURE 31 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY END USER, CAGR (2021-2028)
FIGURE 32 MIDDLE EAST & AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY END USER, LIFELINE CURVE
FIGURE 33 MIDDLE EAST AND AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: SNAPSHOT (2020)
FIGURE 34 MIDDLE EAST AND AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY COUNTRY (2020)
FIGURE 35 MIDDLE EAST AND AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY COUNTRY (2021 & 2028)
FIGURE 36 MIDDLE EAST AND AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY COUNTRY (2020 & 2028)
FIGURE 37 MIDDLE EAST AND AFRICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PRODUCT (2021-2028)
FIGURE 38 MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET: COMPANY SHARE 2020 (%)
Metodología de investigación
La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.
La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.
Personalización disponible
Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.